FDA Approves Therapy to Protect Bone Marrow Cells From Effects of Chemotherapy Physician’s Briefing Staff Feb 18, 2021 Physician's Briefing
Combination Monoclonal Antibody Treatment Authorized for COVID-19 Physician’s Briefing Staff Feb 10, 2021 Physician's Briefing
Breyanzi Approved for Certain Types of Large B-Cell Lymphoma Physician’s Briefing Staff Feb 08, 2021 Physician's Briefing
FDA Approves First Monthly Injectable Regimen for HIV Physician’s Briefing Staff Jan 22, 2021 Physician's Briefing
Tagrisso Approved as Adjuvant Therapy for NSCLC With EGFR Mutations Physician’s Briefing Staff 22 Dec, 2020 Physician's Briefing
Xofluza Approved for Postexposure Prevention of Flu Physician’s Briefing Staff 24 Nov, 2020 Physician's Briefing
First Drug Approved to Treat Rare Metabolic Disorder Physician’s Briefing Staff 24 Nov, 2020 Physician's Briefing
FDA Approves Remdesivir for Treatment of COVID-19 Physician’s Briefing Staff 22 Oct, 2020 Physician's Briefing
FDA Approves First Ebola Virus Treatment Physician’s Briefing Staff 15 Oct, 2020 Physician's Briefing
Drug Combo Approved for First-Line Treatment of Mesothelioma HealthDay News 05 Oct, 2020 Consumer News
Drug Combo Approved for First-Line Treatment of Mesothelioma Physician’s Briefing Staff 05 Oct, 2020 Physician's Briefing
Un medicamento de inmunoterapia mejora la supervivencia de los pacientes con cáncer de pulmón HealthDay News 02 Oct, 2020 Consumer News in Spanish
FDA Approves Nucala for Hypereosinophilic Syndrome Physician’s Briefing Staff 29 Sep, 2020 Physician's Briefing
Enspryng Approved to Treat Neuromyelitis Optica Spectrum Disorder Physician’s Briefing Staff 19 Aug, 2020 Physician's Briefing
Drug Granted Accelerated Approval for Rare Duchenne Muscular Dystrophy Mutation HealthDay News 13 Aug, 2020 Consumer News
